Aastrom Biosciences, Inc. to Present at the Sixth Annual JMP Securities Healthcare Conference

ANN ARBOR, Mich., Sept. 23, 2011 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), the leading developer of patient-specific, expanded multicellular therapies for the treatment of severe, chronic cardiovascular diseases, today announced that company president and CEO Tim Mayleben will speak at the sixth annual JMP Securities Healthcare Conference, which is being held September 27-28, 2011, at the St. Regis Hotel in New York City.
MORE ON THIS TOPIC